SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Archit Organosys informs about outcome of board meeting

21 Oct 2016 Evaluate

Archit Organosys has informed that the Board of Directors of the Company at its meeting held on October 20, 2016, has considered, approved and adopted the Draft Letter of Offer for submitting with the Securities and Exchange Board of India and BSE with respect of issue of Equity shares having face value or Rs 10 each on right basis to the existing shareholders of the Company; Authorised Compliance Officer of the Company for making Public Announcement in the newspapers with respect to filing the Draft Letter of Offer with the Securities and Exchange Board of India.

The above information is a part of company’s filings submitted to BSE.

Archit Organosys Share Price

49.03 3.81 (8.43%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×